These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 33281965)

  • 1. Circulating exosomal miR-125a-5p as a novel biomarker for cervical cancer.
    Lv A; Tu Z; Huang Y; Lu W; Xie B
    Oncol Lett; 2021 Jan; 21(1):54. PubMed ID: 33281965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma exosomal miR-125a-5p and miR-141-5p as non-invasive biomarkers for prostate cancer.
    Li W; Dong Y; Wang KJ; Deng Z; Zhang W; Shen HF
    Neoplasma; 2020 Nov; 67(6):1314-1318. PubMed ID: 32614237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating exosomal miR-125a-3p as a novel biomarker for early-stage colon cancer.
    Wang J; Yan F; Zhao Q; Zhan F; Wang R; Wang L; Zhang Y; Huang X
    Sci Rep; 2017 Jun; 7(1):4150. PubMed ID: 28646161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exosomal miR-99a-5p is elevated in sera of ovarian cancer patients and promotes cancer cell invasion by increasing fibronectin and vitronectin expression in neighboring peritoneal mesothelial cells.
    Yoshimura A; Sawada K; Nakamura K; Kinose Y; Nakatsuka E; Kobayashi M; Miyamoto M; Ishida K; Matsumoto Y; Kodama M; Hashimoto K; Mabuchi S; Kimura T
    BMC Cancer; 2018 Nov; 18(1):1065. PubMed ID: 30396333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive microRNA analysis identifies miR-24 and miR-125a-5p as plasma biomarkers for rheumatoid arthritis.
    Murata K; Furu M; Yoshitomi H; Ishikawa M; Shibuya H; Hashimoto M; Imura Y; Fujii T; Ito H; Mimori T; Matsuda S
    PLoS One; 2013; 8(7):e69118. PubMed ID: 23874885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RNA-Seq Identifies Circulating miR-125a-5p, miR-125b-5p, and miR-143-3p as Potential Biomarkers for Acute Ischemic Stroke.
    Tiedt S; Prestel M; Malik R; Schieferdecker N; Duering M; Kautzky V; Stoycheva I; Böck J; Northoff BH; Klein M; Dorn F; Krohn K; Teupser D; Liesz A; Plesnila N; Holdt LM; Dichgans M
    Circ Res; 2017 Sep; 121(8):970-980. PubMed ID: 28724745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Panel of Plasma Exosomal miRNAs as Potential Biomarkers for Differential Diagnosis of Thyroid Nodules.
    Liang M; Yu S; Tang S; Bai L; Cheng J; Gu Y; Li S; Zheng X; Duan L; Wang L; Zhang Y; Huang X
    Front Genet; 2020; 11():449. PubMed ID: 32508877
    [No Abstract]   [Full Text] [Related]  

  • 8. A plasma mir-125a-5p as a novel biomarker for Kawasaki disease and induces apoptosis in HUVECs.
    Li Z; Jiang J; Tian L; Li X; Chen J; Li S; Li C; Yang Z
    PLoS One; 2017; 12(5):e0175407. PubMed ID: 28467514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating Exosomal miRNAs as Novel Biomarkers for Stable Coronary Artery Disease.
    Zhang P; Liang T; Chen Y; Wang X; Wu T; Xie Z; Luo J; Yu Y; Yu H
    Biomed Res Int; 2020; 2020():3593962. PubMed ID: 33381550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-Throughput Sequencing-Based Identification of Serum Exosomal Differential miRNAs in High-Grade Glioma and Intracranial Lymphoma.
    Wang S; Xu Z; Zhang C; Yu R; Jiang J; Wang C; Qu C
    Biomed Res Int; 2020; 2020():2102645. PubMed ID: 33083454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma Exosomal miR-450b-5p as a Possible Biomarker and Therapeutic Target for Transient Ischaemic Attacks in Rats.
    Luo X; Wang W; Li D; Xu C; Liao B; Li F; Zhou X; Qin W; Liu J
    J Mol Neurosci; 2019 Dec; 69(4):516-526. PubMed ID: 31368061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exosomal encapsulation of miR-125a-5p inhibited trophoblast cell migration and proliferation by regulating the expression of VEGFA in preeclampsia.
    Xueya Z; Yamei L; Sha C; Dan C; Hong S; Xingyu Y; Weiwei C
    Biochem Biophys Res Commun; 2020 May; 525(3):646-653. PubMed ID: 32122654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of non-invasive biomarkers for chronic atrophic gastritis from serum exosomal microRNAs.
    Liu H; Li PW; Yang WQ; Mi H; Pan JL; Huang YC; Hou ZK; Hou QK; Luo Q; Liu FB
    BMC Cancer; 2019 Feb; 19(1):129. PubMed ID: 30736753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor-derived circulating exosomal miR-342-5p and miR-574-5p as promising diagnostic biomarkers for early-stage Lung Adenocarcinoma.
    Han Z; Li Y; Zhang J; Guo C; Li Q; Zhang X; Lan Y; Gu W; Xing Z; Liang L; Li M; Mi S
    Int J Med Sci; 2020; 17(10):1428-1438. PubMed ID: 32624699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Downregulation of serum exosomal miR-150-5p is associated with poor prognosis in patients with colorectal cancer.
    Zou SL; Chen YL; Ge ZZ; Qu YY; Cao Y; Kang ZX
    Cancer Biomark; 2019; 26(1):69-77. PubMed ID: 31306108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma-derived exosomal miR-15a-5p as a promising diagnostic biomarker for early detection of endometrial carcinoma.
    Zhou L; Wang W; Wang F; Yang S; Hu J; Lu B; Pan Z; Ma Y; Zheng M; Zhou L; Lei S; Song P; Liu P; Lu W; Lu Y
    Mol Cancer; 2021 Mar; 20(1):57. PubMed ID: 33781255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Importance of miR-125a-5p and miR-122-5p expression in patients with HBV infection.
    Lak R; Yaghobi R; Garshasbi M
    Cell Mol Biol (Noisy-le-grand); 2020 Jul; 66(5):1-8. PubMed ID: 33040804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating microRNAs from the miR-106a-363 cluster on chromosome X as novel diagnostic biomarkers for breast cancer.
    Li M; Zhou Y; Xia T; Zhou X; Huang Z; Zhang H; Zhu W; Ding Q; Wang S
    Breast Cancer Res Treat; 2018 Jul; 170(2):257-270. PubMed ID: 29557526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating hsa-let-7e-5p and hsa-miR-125a-5p as Possible Biomarkers in the Diagnosis of Major Depression and Bipolar Disorders.
    Gecys D; Dambrauskiene K; Simonyte S; Patamsyte V; Vilkeviciute A; Musneckis A; Butkute-Sliuoziene K; Lesauskaite V; Zemaitis L; Usaite D; Adomaitiene V
    Dis Markers; 2022; 2022():3004338. PubMed ID: 35178127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Profiling analysis of circulating microRNA expression in cervical cancer.
    Nagamitsu Y; Nishi H; Sasaki T; Takaesu Y; Terauchi F; Isaka K
    Mol Clin Oncol; 2016 Jul; 5(1):189-194. PubMed ID: 27330796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.